Despite AngioDynamics's price surge, its low P/S ratio shows...

Despite AngioDynamics's price surge, its low P/S ratio shows investor worries over weak revenue growth prospects. Analysts see the P/S ratio as justified without major revenue gains, suggesting limited hopes for near-term stock rises.